Health care utilization and behavior changes after workplace genetic testing at a large US health care system

Charnysh, Elizabeth; Pal, Subhamoy; Reader, Jonathan M.; Uhlmann, Wendy R.; McCain, Sarah; Sanghavi, Kunal; Blasco, Drew; Brandt, Rachael; Feero, William Gregory; Ferber, Rebecca; Giri, Veda N.; Hendy, Katherine; Prince, Anya E.R.; Lee, Charles; Roberts, J. Scott; Crumpler, Nicole; Leader, Amy; Mathews, Debra; Ryan, Kerry; Spector-Bagdady, Kayte; Vogle, Alyx; Brothers, Kyle; Clayton, Ellen Wright; Deverka, Patricia; Ellis, Thomas; Goldenberg, Aaron; Mockus, Susan; Morton, Cynthia Casson; Rueter, Jens; Witham, Brett; Bessey, Ethan; Gordon, Erynn; Lee, LaTasha; Roberts, Jessica; Saidi, Fatima

doi:10.1016/j.gim.2024.101160

Cited by 2 publications

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?

Briscoe,

Maxwell,

Bourgoin

2024

Front. Genet.

View full text Add to dashboard Cite

Voluntary genetic testing (GT) leverages low-cost DNA sequencing and other testing methods to provide genetic risk screening for healthy individuals. Given the potential to prevent disease and promote health, some employers now offer GT as an employee benefit (workplace GT, or wGT), but participation remains low. To investigate facilitators and barriers to wGT participation, we conducted one of the first representative surveys of working U.S. adults on this topic (n = 958). We assessed factors that could influence participation, including: sponsoring entity (health provider or employer), program design, and individual demographics. Two-thirds (68%) of respondents indicated willingness to participate in some type of GT, but only half (49%) expressed willingness to participate through their employer. Women were 60% more willing to participate than men, and individuals with previous genetic testing experience were 143% more willing to participate than those without such experience. Across all demographic groups, certain GT program design features tended to increase or decrease willingness to participate. The ability to have one’s data deleted from the GT database increased willingness most often (true for 67% of respondents), while selling data to pharmaceutical companies decreased willingness most often (true for 63% of respondents).

show abstract

Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?

Briscoe,

Maxwell,

Bourgoin

2024

Front. Genet.

View full text Add to dashboard Cite

show abstract

Global Perspectives on Pharmacogenomics and Drug Discovery

Rajakumari,

Shri,

Logesh

et al. 2024

Advances in Medical Technologies and Clinical Practice

View full text Add to dashboard Cite

Pharmacogenomics, the study of how genes influence an individual's response to drugs, is changing the scene of medication disclosure and improvement by joining pharmacology and genomics to make powerful, custom-made to an individual's hereditary profile. This arising field is vital in customized medication, where medicines are upgraded in light of individual hereditary varieties. This chapter offers an in-depth exploration of the global impact of pharmacogenomics, underscoring key examination foundations and undertakings, moral contemplations, difficulties and future headings. The joint efforts exhibit the capability of joint endeavor to defeat difficulties and advance the field by fitting worldwide guidelines and creating strategies that help even-handed admittance to pharmacogenomic progressions are significant for the worldwide reconciliation of customized medication.

show abstract

Health care utilization and behavior changes after workplace genetic testing at a large US health care system

Cited by 2 publications

References 30 publications

Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?

Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?

Global Perspectives on Pharmacogenomics and Drug Discovery

Contact Info

Product

Resources

About